Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Mavorixafor

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5X4 PHARMS

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    X4 PHARMS

    MAVORIXAFOR

    arrow
    BioFlorida Conference
    Not Confirmed

    X4 PHARMS

    Country
    arrow
    BioFlorida Conference
    Not Confirmed

    Patent Expiration Date : 2036-12-22

    MAVORIXAFOR

    US Patent Number : 11219621

    Drug Substance Claim :

    Drug Product Claim :

    Application Number : 218709

    Patent Use Code : U-3932

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2036-12-22

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    X4 PHARMS

    MAVORIXAFOR

    arrow
    BioFlorida Conference
    Not Confirmed

    X4 PHARMS

    Country
    arrow
    BioFlorida Conference
    Not Confirmed

    Patent Expiration Date : 2036-12-22

    MAVORIXAFOR

    US Patent Number : 10610527

    Drug Substance Claim :

    Drug Product Claim :

    Application Number : 218709

    Patent Use Code : U-3932

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2036-12-22

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    X4 PHARMS

    MAVORIXAFOR

    arrow
    BioFlorida Conference
    Not Confirmed

    X4 PHARMS

    Country
    arrow
    BioFlorida Conference
    Not Confirmed

    Patent Expiration Date : 2038-12-11

    MAVORIXAFOR

    US Patent Number : 11045461

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 218709

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2038-12-11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    X4 PHARMS

    MAVORIXAFOR

    arrow
    BioFlorida Conference
    Not Confirmed

    X4 PHARMS

    Country
    arrow
    BioFlorida Conference
    Not Confirmed

    Patent Expiration Date : 2036-12-14

    MAVORIXAFOR

    US Patent Number : 10953003

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 218709

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2036-12-14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    X4 PHARMS

    MAVORIXAFOR

    arrow
    BioFlorida Conference
    Not Confirmed

    X4 PHARMS

    Country
    arrow
    BioFlorida Conference
    Not Confirmed

    Patent Expiration Date : 2038-12-11

    MAVORIXAFOR

    US Patent Number : 10548889

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 218709

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2038-12-11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF